Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2
1 other identifier
interventional
115
1 country
1
Brief Summary
The goal of this study is to assess patients' attitudes and knowledge of Hepatitis C, analyze the variables that may influence patients' knowledge, and educate patients on Hepatitis C.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2017
CompletedFirst Posted
Study publicly available on registry
October 25, 2017
CompletedStudy Start
First participant enrolled
October 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 26, 2019
CompletedAugust 28, 2019
August 1, 2019
1.8 years
October 2, 2017
August 26, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Questions Scored Correct on the Hepatitis C Knowledge Survey
Number of questions scored correct on the Hepatitis C knowledge survey
2-8 weeks after study intervention
Study Arms (2)
Pamphlets plus Review with Expert Educator
OTHEREducational Intervention includes Pamphlets plus Review with Expert Educator
Pamphlets only
OTHEREducational Intervention includes Pamphlets only
Interventions
Patients will be randomized to a group that receives the pamphlets only and a group that receives the pamphlets and has an expert educator review that pamphlets with them and answer questions.
Eligibility Criteria
You may qualify if:
- Study population includes Faculty Medical Center obstetrics and postpartum patients enrolled in the HOPE program who are 18 years old or older.
- The study will include patients with and without a Hepatitis C diagnosis.
- Patients will be recruited at their routine office visits and/or during any admissions to the hospital.
You may not qualify if:
- Patients who do not speak and understand English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TriHealth Inc.lead
Study Sites (1)
Good Samaritan Hospital
Cincinnati, Ohio, 45220, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Marcotte, MD
TriHealth Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2017
First Posted
October 25, 2017
Study Start
October 30, 2017
Primary Completion
August 26, 2019
Study Completion
August 26, 2019
Last Updated
August 28, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share